Purchase Order SPE2DP25V0372
Award Date
11/22/24
Potential Completion Date
12/9/24
Potential Value
$3K
Federal Agency
Medical Supply Chain
Awardee
The Maclean Group LLC
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sacramento, CA 95825, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,010.06 firm-fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride, a medication used to reverse opioid overdose. This contract has an ultimate completion date of May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several...
This $1,005.03 firm fixed-price purchase order was awarded by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Jacksonville, Florida. The contract is for the delivery of 8511011937 (Naloxone Hydrochloride) and has a period of performance through November 27, 2024. The Maclean Group LLC is an ISO 9001:2015 certified medical and pharmaceutical wholesale...
This federal contract was awarded by the Department of Defense's Medical Supply Chain agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The $3,015.09 firm fixed-price purchase order is for the supply of naloxone hydrochloride, a critical medication used to reverse opioid overdoses. The contract has an ultimate completion date of August 16, 2024 and was awarded on August 1, 2024 with no set-aside designation. The...
This contract was awarded to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, to provide naloxone hydrochloride, a medication used to reverse opioid overdose. The $1,005.03 firm fixed-price purchase order was issued by the Defense Logistics Agency's Medical Supply Chain division. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded numerous prime federal...
This is a firm fixed-price purchase order contract awarded by the Medical Supply Chain division of the U.S. Defense Logistics Agency to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The $3,015.09 contract is for the supply of naloxone hydrochloride, an opioid overdose reversal drug. The contract has a period of performance ending on May 31, 2024 and was awarded on May 16, 2024. The Maclean Group is an ISO 9001:2015 certified medical and...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency's Medical Supply Chain to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The $3,015.09 contract is for the delivery of NALOXONE HYDROCHLORIDE. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that provides a wide range of products and services to various federal agencies, including...
This is a firm fixed price purchase order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract, valued at $2,010.06, is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has a performance period ending on May 10, 2024. The Maclean Group is an ISO 9001:2015 certified...
The U.S. Department of Defense's Medical Supply Chain agency has awarded a firm fixed-price purchase order contract valued at $1,005.03 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has an ultimate completion date of May 10, 2024. The Maclean Group is an ISO 9001:2015 certified medical and...
This firm-fixed-price purchase order was awarded to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, to provide naloxone hydrochloride to the Defense Logistics Agency's Medical Supply Chain. The $1,005.03 contract has an ultimate completion date of August 1, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded multiple federal contracts, including a...
The U.S. Department of Defense's Medical Supply Chain agency awarded a $2,010.06 firm-fixed-price purchase order to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the delivery of naloxone hydrochloride. This contract, awarded on October 1, 2024 with an ultimate completion date of October 16, 2024, is not designated as a set-aside. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale...